outsourcing
Outsource to China, Then Move There?
Yesterday’s note on the increasing costs in China led several commenters to mention that the cost savings of outsourcing work are never exactly what the percentages might lead you to think.
HHS report underscores big shift to foreign drug trials
A new report from the inspector general of HHS highlights just how dependent drug developers have become on overseas clinical trials. And the New York Times raises some serious questions over the kind of regulatory oversight, or lack of it, that foreign drug trials are subject to. According to the HHS report, 80 percent of all the drugs approved in 2008 relied on foreign trials to some extent, with 78 percent of all enrollees recruited at foreign sites.
52 Perspectives: “Current Outlook on Conducting Clinical Trials in India.�
This week’s submission comes to us from Jim Worrell, CEO of  Pharma Services Network. Since 2002, Pharma Services Network has helped biopharma sponsors find the right CRO partners with a growing emphasis on India. Q. How popular is India as a country of choice for American or European sponsors?
52 Perspectives: œTrends in Pharmaceutical Contract Manufacturing
This week’s submission of œ52 Perspectives comes to us from Dr. Scott Wheelwright.
Contract Research on the Rise
Reprint from the Scientist magazine. The global economic crisis has got most businesses pinching pennies just to stay afloat, and the drug development industry is no exception. But at least one area of the biotechnology sector — contract research organizations (CROs) — is on the rise
Read the full storyThe US FDA establishes presence in India
Pharmaceutical Outsourcing Congress sponsored an event where the head FDA inspector gave an overview of the FDA’s role in India.
Are you a CRO or CMO? œDo™s and Don™ts to getting business
Summer 2005, and I am waiting in a conference room in a Seoul hotel with the press. We are about to announce what will become the largest biologics outsourcing agreement in Asia
5 reasons to rate a Pharma Outsourcing Partner
You may have heard that the pharmaceutical outsourcing industry now has it’s own rating site. That’s right.
How Partner ratings are policed on goBalto
We take the integrity of the Partner rating system seriously, and devote considerable resources to ensure members are presented with a fair and balanced view of the Partners which are rated. We also recognize that no system is perfect and we are the first to admit the limitations of any rating system. To address the most
52 Perspectives: œWell defined Preclinical Trial models
This week’s submission of “52 Perspectives” comes to us from Kevin Baker. Kevin is the co-founder of External Pharma, a leading provider of preclinical and drug discovery services and currently serves as director of service and strategic development





